THYROID PROJECTS

Other Projects & Clinical Trials

The latest UK Thyroid Cancer Clinical Trial IoN is well underway, with more than 110 patients who are already taking part in this important study of thyroid cancer.

The UK HiLo study results were reported in the top medical journal, the New England Journal of Medicine, in May 2012. It showed that selected patients with well-differentiated thyroid cancer could now be given a low dose of radioactive iodine for ablation, instead of the usual high dose, if the whole thyroid gland has been removed by a specialist surgeon.